BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 25241792)

  • 1. [Analysis of the risk factors for local recurrence of giant cell tumor of long bone].
    Xu H; Niu X
    Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):465-8. PubMed ID: 25241792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for recurrence of giant cell tumours of bone.
    Siddiqui MA; Seng C; Tan MH
    J Orthop Surg (Hong Kong); 2014 Apr; 22(1):108-10. PubMed ID: 24781627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher local recurrence rates after intralesional surgery for giant cell tumor of the proximal femur compared to other sites.
    Errani C; Tsukamoto S; Leone G; Akahane M; Cevolani L; Tanzi P; Kido A; Honoki K; Tanaka Y; Donati DM
    Eur J Orthop Surg Traumatol; 2017 Aug; 27(6):813-819. PubMed ID: 28589498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for local recurrence in extremity-located giant cell tumours of bone with pathological fracture.
    Medellin MR; Fujiwara T; Tillman RM; Jeys LM; Gregory J; Stevenson JD; Parry M; Abudu A
    Bone Joint J; 2018 Dec; 100-B(12):1626-1632. PubMed ID: 30499317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Meta-analysis of risk factors of recurrence in patients with giant cell tumor on extremities].
    Li R; Hu Y
    Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(47):3778-83. PubMed ID: 25623108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surgical treatment of giant cell tumors with pathological fracture around the knee].
    Liu WF; Yang FJ; Li Y; Li B; Hao L; Niu XH
    Zhonghua Wai Ke Za Zhi; 2018 Sep; 56(9):677-686. PubMed ID: 30157574
    [No Abstract]   [Full Text] [Related]  

  • 7. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
    Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
    World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical treatment for long bone giant cell tumor of extremity with pathologic fracture].
    Li X; Guo W; Yang Y; Wei R; DU ZY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 45(5):745-51. PubMed ID: 24136271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors of local recurrence of giant cell tumor of long bone after treatment: plain radiographs, pathology and surgical procedures.
    Chanchairujira K; Jiranantanakorn T; Phimolsarnti R; Asavamongkolkul A; Waikakul S
    J Med Assoc Thai; 2011 Oct; 94(10):1230-7. PubMed ID: 22145509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution.
    Niu X; Zhang Q; Hao L; Ding Y; Li Y; Xu H; Liu W
    J Bone Joint Surg Am; 2012 Mar; 94(5):461-7. PubMed ID: 22398741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of giant-cell tumors of long bones with curettage and bone-grafting.
    Blackley HR; Wunder JS; Davis AM; White LM; Kandel R; Bell RS
    J Bone Joint Surg Am; 1999 Jun; 81(6):811-20. PubMed ID: 10391546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Case analysis on treatment and recurrence of giant cell tumor of bone].
    Zhang Z; Zhu B; Sun T
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1007-10. PubMed ID: 17140075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended intralesional curettage preferred over resection-arthrodesis for giant cell tumour of the distal radius.
    Abuhejleh H; Wunder JS; Ferguson PC; Isler MH; Mottard S; Werier JA; Griffin AM; Turcotte RE
    Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):11-17. PubMed ID: 31297594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant Cell Tumor (tumor gigantocellularis, osteoclastoma) - epidemiology, diagnosis, treatment.
    Karpik M
    Ortop Traumatol Rehabil; 2010; 12(3):207-15. PubMed ID: 20675862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical studies on effect of bone cement filling on articular cartilage of the knee after curettage of giant cell tumor].
    Cao W; Ye Z; Lin N; Liu M
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Dec; 28(12):1459-63. PubMed ID: 25826886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segmental excision versus intralesional curettage with adjuvant therapy for giant cell tumour of bone.
    Yacob O; Umer M; Gul M; Qadir I
    J Orthop Surg (Hong Kong); 2016 Apr; 24(1):88-91. PubMed ID: 27122520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
    Gouin F; Dumaine V;
    Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giant cell tumor of bone: oncological and functional results of long-term follow-up.
    Oda Y; Miura H; Tsuneyoshi M; Iwamoto Y
    Jpn J Clin Oncol; 1998 May; 28(5):323-8. PubMed ID: 9703860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Strategy of Curettage and Adjuvant Microwave Therapy for the Treatment of Giant Cell Tumor of Bone in Extremities: A Preliminary Study.
    Ke J; Cheng S; Yao MY; Chu X; Wang M; Zeng XL; Yang T; Zhang C; Zhong H; Zhang Y
    Orthop Surg; 2021 Feb; 13(1):185-195. PubMed ID: 33442922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supplemental Bone Grafting in Giant Cell Tumor of the Extremity Reduces Nononcologic Complications.
    Benevenia J; Rivero SM; Moore J; Ippolito JA; Siegerman DA; Beebe KS; Patterson FR
    Clin Orthop Relat Res; 2017 Mar; 475(3):776-783. PubMed ID: 26932739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.